Skip to main content
2026 CRT Conference Main banner

Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC

Interventional Cardiologist
John Muir Health Cardiovascular Institute
San Francisco, California, United States

Dr. Gershony is an interventional cardiologist who trained at Emory University under Andreas Gruentzig. He was the Director of Cardiovascular Research, Education and Technology at John Muir Health in the Bay Area until 2022. Dr. Gershony’s research interests include novel devices for complex angioplasty, percutaneous valve therapies and local drug-delivery to prevent restenosis. He has participated in numerous clinical trials as a PI and has authored over 100 manuscripts, patent applications and abstracts.
Dr. Gershony was the Founder of Vascular Solutions, which had a successful IPO and for which he served as CMO and a member of the BOD. He was also the Founder and CMO of AngioScore until its successful acquisition by Spectranetics/Philips.
Dr. Gershony is a founding General Partner of BayMed Venture Partners, which is focused on early-stage Medical Device and Digital Health companies in the U.S. and Israel.

Disclosure(s): AtaCor: Stock Options [in privately held companies] (Ongoing)

Presentation(s):